Select a community
Mood Conditions including Depression, Anxiety, Bipolar, OCD, and PTSD
Find out more about the PatientsLikeMe
Mood Conditions Community
Home > Community Treatment Reports > Lidocaine Transdermal Treatment Report
What is Lidocaine Transdermal?

Lidocaine is a local anesthetic. It works by stopping nerves from sending pain signals. Lidocaine comes as a transdermal patch applied directly to the skin for localized relief of acute hypersensitivity and chronic pain in postherpetic neuralgia. Read more...Click to read more below

Reasons taken & Efficacy

Reasons and Efficacy
Reasons taken # of patients Major Moderate Slight None Can’t tell # of patients evaluated by
Back pain 4 1
Pain 1 0
Other 1 0
Lower back pain 1 1
Neck Pain 1 1
foot pain, knee pain 1 0

Mouse over the table for more information

Side Effects

Side effects as an overall problem

Severe
0 0%
Moderate
0 0%
Mild
0 0%
None
3 100%

Dosages

  1 as needed 3other as needed 5 as needed 5% as needed 700mg as needed 2 other daily 5 g daily 50 mg daily
  1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1  

Stop Reasons

Why Patients Stopped Taking Lidocaine Transdermal (multiple reasons could be selected)
Reason # Patients Percentage of patients
Course of treatment ended
1 100% Course of treatment ended: 100%

See all 1 patient who’ve stopped taking Lidocaine Transdermal

Currently Taking Lidocaine Transdermal

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
1
2

Stopped Taking Lidocaine Transdermal

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
1
0
0
0
0
0

Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Always
2 67%
Usually
1 33%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Very
0 0%
Somewhat
0 0%
A little
1 33%
Not at all
2 67%

Cost

Paid out of pocket

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
0 0%
< $25
2 67%

Report created on November 23, 2009.